16 October 2021, 10: 30-12: 00. Dr. Rigakos participated in the ROUND TABLE: Ηormone Combinations in Hormone Sensitive HER2 Negative Breast Cancer where he gave a talk on PIK3CA inhibitors, in the context of the 6th Scientific Forum entitled “Bio-Sciences, Innovation, Technology and Cancer: From Prevention to Treatment”, which took place at the Divani Caravel Hotel in Athens under the auspices of the Hellenic Society of Oncologists (EOPE), the Hellenic Collaborating Oncology Group (HeCOG) and in collaboration with the Scientific Society of Medical Students of Greece.
Leave a Reply